March 2009
Worldwide Biotech;Mar2009, Vol. 21 Issue 3, p4
Trade Publication
This article reports on a fund raised by KAHR Medical from Hadasit Bio-Holdings (HBL) and the Office of the Chief Scientist of the Ministry of Industry, Trade and Labor of Israel (OCS) in 2009. The financing will support further development of the product pipeline of KAHR Medical. The company also plans to begin an external financing round before the end of 2009 to support its clinical program.


Related Articles

  • Financings Roundup.  // BioWorld Today;1/29/2009, Vol. 20 Issue 18, p5 

    The article reports that Jerusalem-based KAHR Medical Ltd. has raised $500,000 from the Office of the Chief Scientist of the Ministry of Industry, Trade and Labor of Israel and from existing investor Hadasit Bio-Holdings Ltd. The company which has raised $1.5 million to date is developing a...

  • Clinic Roundup.  // BioWorld Today;10/25/2012, Vol. 23 Issue 208, p3 

    This section offers news briefs on clinical trials as of October 25, 2012. An open-label Phase II trial testing Hsp90 inhibitor AT13387 was opened by Astex Pharmaceuticals Inc. BioLineRx Ltd. is planning to conduct an interim analysis of the Phase II/III CLARITY trial of BL-1020. A clinical...

  • Financings Roundup.  // BioWorld Today;1/23/2013, Vol. 24 Issue 15, p2 

    The article offers news briefs related to biopharmaceutical industry including the public offering of AVEO Pharmaceuticals Inc., the $703,000 in convertible loans raised by Hadasit Bio-Holdings Ltd., and the nonbrokered private placement of $2 million taken by Sernova Corp.

  • Finding Gems in Junk, RaNA Emerges with $21M Series A.  // BioWorld Today;1/19/2012, Vol. 23 Issue 12, p1 

    This section offers news briefs on financing deals in the biopharmaceutical market. A total of 20.7 million U.S. dollars was raised by RaNA Therapeutics Inc. via a Series A financing round led by Atlas Venture, SR One and Monsanto Co. Connecticut Innovations has invested 500,000 U.S. dollars...

  • Measuring the effect of public assistance programs on small businesses' performance. Schayek, Kami; Dvir, Dov // Journal of General Management;Winter2009/2010, Vol. 35 Issue 2, p3 

    Data gathered on small trade and service businesses that participated in a coaching project initiated by the Ministry of Industry, Trade and Labor in Israel was used to assess the effect of public assistance programs on small businesses' performance. A multi-dimensional framework. was developed...

  • Clinic Roundup.  // BioWorld Today;8/4/2011, Vol. 22 Issue 150, p7 

    This section offers news briefs related to clinical trials in the biotechnology industry. AB Science SA has enrolled its first patient for the Phase IIb/III study of masitinib in rheumatoid arthritis. Thrombotech, the portfolio company of Hadasit Bio-Holdings Ltd. and Clal Biotechnology...

  • Swords into ploughshares. Butler, Declan // Nature;6/29/1995, Vol. 375 Issue 6534, p727 

    Reports on the plan of Israel's Ministry of Industry and Trade (MIT) to pay out more in subsidies for industrial research in 1995. Funding provided by MIT for research projects; Launching of the program MAGNET to encourage companies to collaborate on `pre-competitive' generic research; Israel's...

  • New funding granted to Tower.  // Electronic News;1/22/96, Vol. 42 Issue 2100, p12 

    Reports that Tower Semiconductor Ltd. received approval of its application for additional grants under the Investment Center of the Israeli Ministry of Industry and Trade's Approved Enterprise Program. Details of the funding in the form of grants.

  • FINANCINGS.  // BioWorld Today;9/12/2013, Vol. 24 Issue 175, p5 

    The article explains the focus of the initiative of Kahr Medical Ltd., a portfolio company of Hadasit Bio-Holdings, to raise 2.5 million dollars of which 1.65 million dollars will come from Flerie Invest AB, a company controlled by Thomas Eldered.


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics